跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIBGEN iobenguane[123I] sulfate 100MBq/mL injection - TGA Drug Approval Details
Approvals
/
TGA
/
MIBGEN iobenguane[123I] sulfate 100MBq/mL injection
Approved
STANDARD
MIBGEN iobenguane[123I] sulfate 100MBq/mL injection
Australian Nuclear Science and Technology Organisation T/A ANSTO
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
06f5a1b06f7c48be
Company
Australian Nuclear Science and Technology Organisation T/A ANSTO
Type
Standard
Approval Details
Approval Id
06f5a1b06f7c48be
Product Name
MIBGEN iobenguane[123I] sulfate 100MBq/mL injection
Artg Id
101670
Artg Name
MIBGEN iobenguane[123I] sulfate 100MBq/mL injection vial
Sponsor
Australian Nuclear Science and Technology Organisation T/A ANSTO
Company Detail Path
/organization/australian-nuclear-science-and-technology-organisation-lucas-heights-new-south-wales-australia
Artg Date
2004-06-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-CMI-01497-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
06f5a1b06f7c48be
Type
Standard
Back to TGA Approvals